Modafinil — prescription, personal import, and the regulatory landscape

A reference on the prescription requirements across major jurisdictions and the personal-import policies that allow generic supply to reach buyers who don’t have one.

Modafinil is prescription-only, almost everywhere

In all major regulated markets, modafinil is dispensed only with a prescription from a licensed physician. There is no over-the-counter modafinil market in the U.S., U.K., EU, Canada, Australia, or Japan. The drug is not classified as a narcotic; it sits in the prescription medicine tier (Schedule IV in the U.S., POM in the U.K., Schedule 4 in Australia, Schedule F in Canada).

This is the regulatory baseline. The question of where and how a buyer obtains modafinil without a prescription is a separate question, and one the personal-import frameworks address.

Personal-import policies

Several jurisdictions explicitly permit individuals to import small quantities of prescription medication for their personal use, distinct from commercial importation. These policies were designed before the internet to let travelers carry essential medications across borders; in practice they accommodate mail-order direct import as well.

U.S. FDA personal-import policy: typically a 90-day supply or less for personal use, applied at customs discretion. U.K. Home Office personal-import: a three-month supply per personal-import allowance. Australia TGA personal-import scheme: up to three months’ supply for individual use. Canada, personal-import allowances for individual use under Schedule F. EU member states: implementation varies but personal-quantity importation is generally accommodated.

What “personal-import” doesn’t mean

Personal-import policies are not blanket legalizations. The buyer is acting under a personal-quantity allowance, not exempt from drug law. Importing larger quantities crosses the threshold into commercial importation, which most personal-import frameworks treat differently and which carries different legal exposure. Razumna’s wholesale tier (5,000+ tablets) is structured for buyers operating under business arrangements rather than personal-import allowances.

Telemedicine prescription

For buyers who want a prescription rather than personal import, telemedicine providers in many jurisdictions can issue modafinil prescriptions after an appropriate consultation. In the U.S., Schedule IV prescriptions can be issued via telehealth under post-2020 regulatory updates. The U.K. has online clinic models; Australia and Canada have similar telehealth pathways.

The trade-off is that prescription pharmacy prices in the U.S. and U.K. run two to twenty times razumna’s direct-import price. The prescription removes the customs question. The pricing differential is the reason most buyers operating off-label choose personal import.

razumna’s position

Razumna ships under the assumption that buyers are operating within their own jurisdiction’s personal-import framework. Razumna does not issue prescriptions, does not pretend to be a clinical service, and does not certify that personal import is legal in a given buyer’s specific situation. The buyer’s terms of purchase explicitly place responsibility for legality on the buyer.

This is honest framing rather than a disclaimer. The legal asymmetry, modafinil is regulated, but personal import is permitted, is the reason direct-import vendors exist. Razumna operates inside that asymmetry; the buyer who participates is doing the same.

Related

For per-country legal detail, see modafinil legality by country. For razumna’s customs handling, see customs & replacement.